Galectin Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:PHPN Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
23 Dec 25	Buy€2,217	Kary Eldred	Individual	700	€3.17
23 Dec 25	Buy€16,571	Kevin Freeman	Individual	5,500	€3.01
16 Dec 25	Sell€173,542	10x Capital Management, LLC	Company	30,681	€5.66
03 Dec 25	Sell€789,449	10x Capital Management, LLC	Company	162,069	€4.91
11 Nov 25	Sell€181,083	10x Capital Management, LLC	Company	40,000	€4.53
22 Oct 25	Sell€212,544	10x Capital Management, LLC	Company	50,000	€4.25
21 Jul 25	Buy€2,496	Kary Eldred	Individual	1,000	€2.50
17 Jul 25	Buy€12,508	Kevin Freeman	Individual	5,000	€2.50

Insider Trading Volume

Insider Buying: PHPN insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of PHPN?
Owner Type	Number of Shares	Ownership Percentage
Hedge Funds	5,614,457	8.71%
Institutions	10,605,163	16.4%
Individual Insiders	13,100,182	20.3%
General Public	35,152,990	54.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 42.68% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
16.1%	Richard Uihlein	10,348,981	€31.4m	0.1%	no data
8.71%	10x Capital Management, LLC	5,614,457	€17.0m	-5.2%	100.0%
3.49%	The Vanguard Group, Inc.	2,247,967	€6.8m	2.9%	no data
1.88%	Osaic Wealth, Inc.	1,214,724	€3.7m	-3.24%	0.01%
1.62%	James Czirr	1,045,541	€3.2m	0%	no data
1.29%	Joel Lewis	834,592	€2.5m	-9.46%	no data
1.24%	BlackRock, Inc.	797,669	€2.4m	-10.6%	no data
0.98%	Geode Capital Management, LLC	633,067	€1.9m	-4.97%	no data
0.86%	Marshall Wace LLP	554,261	€1.7m	1,720%	no data
0.78%	Kary Eldred	501,334	€1.5m	0.14%	no data
0.74%	Wealthspire Advisors LLC	479,518	€1.5m	0%	0.01%
0.69%	Susquehanna International Group, LLP	446,578	€1.4m	131%	no data
0.56%	LPL Financial LLC	360,268	€1.1m	-1.83%	no data
0.56%	Geneos Wealth Management, Inc.	360,175	€1.1m	-14.9%	0.03%
0.46%	Commonwealth Equity Services, LLC	294,901	€893.7k	3.32%	no data
0.4%	Vivaldi Capital Management LP	255,752	€775.1k	48.3%	0.13%
0.38%	Cross Consulting and Services, LLC	243,745	€738.7k	0%	no data
0.36%	State Street Global Advisors, Inc.	230,340	€698.1k	14.6%	no data
0.35%	Morgan Stanley	224,006	€678.9k	9.84%	no data
0.26%	The Retirement Guys Formula LLC	165,993	€503.1k	4.01%	0.22%
0.24%	Sovran Advisors, LLC	157,405	€477.0k	-16.7%	0.05%
0.24%	Kevin Freeman	153,332	€464.7k	3.72%	no data
0.19%	Cambridge Investment Research Advisors, Inc.	121,204	€367.3k	-0.09%	no data
0.19%	Northern Trust Global Investments	121,065	€366.9k	0.27%	no data
0.17%	Millennium Management LLC	110,422	€334.6k	-23.6%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/01/08 09:43
End of Day Share Price	2026/01/07 00:00
Earnings	2025/09/30
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Galectin Therapeutics Inc. is covered by 6 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Keay Nakae	Ascendiant Capital Markets LLC
Mayank Mamtani	B. Riley Securities, Inc.
Antonio Arce	H.C. Wainwright & Co.